KNOW RX

Physicians, Progress, and Passion all
geared toward Providing better care for Patients.

It is very exciting working with the and their team for the Annual Convention and Science Assembly.

The Training provided by knowRX® is for Principal Investigators, Site Staff or those physicians aspiring to become New Investigators. Available directly through NMA.

See you in at the 2023 Annual Convention and Science Assembly. As part of the Project IMPACT session, and in collaboration with , we will present “New Investigator Training” and speak about its importance to …
Learn more at https://bit.ly/nma2023conf
Special thanks to for the amazing digital portraits of physicians which will be given away at the

Excited share our collaboration with The National Medical Association to support their Annual Convention and Science Assembly.

On Monday, July 31st, attendees are invited to attend “New Investigator Training” for CME credits as part of Project IMPACT’s sessions.

Today we will deliver 150 cases or 6,000 bottles of water to the homeless and cooling centers in

I’m grateful for all this who gave and from the startup/entrepreneur communities and friends that supported this effort on a few days notice.

This started from an idea to buy a case of water for the homeless (You Matter) that are generally along my commute and how of asking the communities I’m in and long time friends how we can have a bigger impact.

To my Friends, Financial Freedom Community and the Astronomic Community, thank you. You showed up and we delivered.

KNOW RX

(whew) is a training campaign that knowRX provides to physicians to educate them on their role in clinical research and the potential needs of their patients as “trusted providers”. 76% of patients want to receive this information from their providers, not Facebook ads or television commercials but from trusted health professional who are invested in their patients. We are working to do that and make it easier for this information exchange to happen. Checkout our website for more information *p

Ma kēia Mahina Hoʻoilina ʻo Asian American, ʻo Native Hawaiian, a me Pacific Islander, ke hoʻopili nei mākou i ke Keʻena Kōkua Ola ʻokoʻa ma ko lākou mau hana e hoʻemi i nā ʻokoʻa ola no ka hoʻoikaika i nā kaiaulu o Asian American, Native Hawaiian, a me Pacific Islander a e loaʻa ka Ola Maikaʻi Ma o ka Maopopo Maikaʻi. ʻIke hou aku: https://minorityhealth.hhs.gov/aanhpihm/

According to the American Optometric Association, is the leading cause of in and ref J1 20/20 line in photo. don’t delay your vision checkups, make an appointment for your annual checkup with your optometrist.

FDA panel votes in favor of the first over-the-counter birth control pill.

https://www.statnews.com/pharmalot/2023/05/10/fda-panel-votes-in-favor-of-the-first-ever-over-the-counter-birth-control-pill/

Thanks Ed Silverman Pharmalot.com

FDA panel votes in favor of the first over-the-counter birth control pill In a highly significant move, a panel of independent experts voted unanimously that the FDA should approve the first over-the-counter birth control bill.

We are committed to helping preserve trees and reduce their consumption for medical prescription fact sheets, which are often disposed of or placed in a cabinet draw. Along with planting new trees, we need to protect the trees we have and reduce paper consumption.

We’ve committed to in 2023 with the ’s program. Join us in creating a positive impact in our community!

Austin Gives Austin Gives, a program of the Austin Chamber, recognizes businesses for excellence in giving back.

Always ready to celebrate and appreciate the women of our world! Thank you!

We are excited to share in another celebration of Black History month and explore the richness of contributions from the African American community.

We are excited to share our Founder and CEO's (David Franklin) inclusion in Entrepreneur's "Top 10 Inspiring Healthcare Entrepreneurs To Watch In 2023."

Top 10 Inspiring Healthcare Entrepreneurs To Watch In 2023 These innovators have already made strides in their respective fields, from revolutionizing treatments for serious illnesses to pioneering new technologies that will improve the industry

We are excited to share in our 4th year as a business. In looking forward, we are forever grateful to our incredible team and all those who have supported our progress along the way. We believe in our “why” and passion and know greater things will
continue to happen this coming year.

Chairman Patrick Leahy (D-Vt.) Releases Fiscal Year 2023 Omnibus Appropriations Bill

https://energycommerce.house.gov/newsroom/press-releases/pallone-and-eshoo-applaud-key-health-care-provisions-in-the-fiscal-year-2023

Clinical Trial Diversity: The omnibus requires FDA to take a series of actions intended to modernize and improve clinical trials, including increasing the diversity and engagement of trial participants.

Pallone and Eshoo Applaud Key Health Care Provisions in the Fiscal Year 2023 Omnibus Government Funding Bill Chairs Pallone and Eshoo applaud key health care provisions in FY23 omnibus.

Wishing everyone a safe and happy Christmas. May the spirit of the day enrich your lives each and every day.

We are exciting to be attending HLTH this week we look forward to speaking about Patient Engagement, DDoH, Diversity, Clinical Trials, and the Trusted Providers. HLTH

Join in tomorrow and listen to our co-founder, James H. Powell, MD speak during the Our 50 Hoops LEGENDS exciting FINALE of The “10 Commandments For Recruiting African Americans Into Clinical Trials” Workshops which will be a VETERAN’S DAY Special.

On Friday, November 11, an extended version of this powerful “How-To” Diversity and Inclusion 10-part Series will be held 12:30-2:00 PM (CT)/1:30-3:00 PM (ET).

With great LIVE interaction, important health-related tips, and clinical trial resources you can take with you.

Registration: https://us02web.zoom.us/webinar/register/WN_d1HjPqh5T16dP9hqhJBzXw

knowRX would like to share our mobile app, “The Owl App”, designed to empower patients on their individual health and wellness journey. We have designed in many benefits because we, like you, have our own journey to manage. Your feedback is always welcomed. Learn more at https://theowlapp.health

As more people use our mobile app, we are able to identify racism and unrecognized bias in prescribing practices. Black patients were 36% less likely to be prescribed Paxlovid, an antiviral drug for COVID-19, than white patients, while Hispanics were 30% less likely to get the drug as noted by the CDC. Currently we are monitoring over 200 patients and over 80 medications throughout the US. When our machine learning incorporates objective input from the community we quickly identify these disparities in health and bring more awareness and access to care which could also mean a clinical trials notification. Learn more about our mobile app here at https://theowlapp.health

Additional benefits include:
Medication reminders
Appointment reminders
Digital Drug Label
Accountability Partner
Health & Wellness Articles

We are currently working on some amazing integrations to help our communities become empowered on their health and wellness journey.

The Owl App - Personalized Medication Management for everyone! Medication Management is important to your health and we all need some guidance. The Owl App is designed to help you manage it easier.

Talk to people where they are. We are glad to exhibit and share “The Owl App” to the Austin community at the Centeal Texas African American Family Support Conference.

More awareness brings better access to care. Helping communities have better conversations with their care team, providers and pharmacist. Having health and wellness content that increase your knowledge along with medication reminders can provide better health outcomes. We empower your health journey and advocate for you. Join today so we can hear directly from you.

Download today at https://theowlapp.health

Thanks to our team who came out to engage and educate.

Looking forward to attending and supporting the Central Texas African American Family Support Conference here in the on Oct 15. Come out and support the community and visit our booth. Register today: https://ctaafsc.com/reunion

Each year, the UCSF Digital Health Awards recognizes the most innovative new technologies in digital health. This year, they will also award an up-and-coming company to keep an eye on in each category: The Rising Star.

We are thrilled to announce our submission to be recognized as Rising Stars in the digital health field on the 2022 Digital Health Awards stage, and eagerly anticipate the results' announcement at the Grand Finale event at the HLTH Conference in Las Vegas November 14th.

Follow our journey to the podium at the UCSF Health Hub Digital Health Awards. For more information on ways to support the 2022 Awards visit https://bit.ly/3dGPL3o.

FDA approves topical treatment addressing repigmentation in vitiligo in patients aged 12 and older.

Vitiligo is considered to be an autoimmune disorder. In people with vitiligo, the immune system appears to attack the pigment cells (melanocytes) in the skin. Many people with vitiligo are also affected by at least one other autoimmune disorder.

FDA approves topical treatment FDA has approved Opzelura (ruxolitinib) cream for the treatment of nonsegmental vitiligo in adult and pediatric patients 12 years of age and older.

� ¿ actualmente no existe una cura única para la enfermedad de células falciformes? Conoce los esfuerzos que se están realizando para ayudar a encontrar una cura que funcione para todos en el sitio web de : minorityhealth.hhs.gov/sicklecell/

Watch the HHS Office of Minority Health (OMH) Sickle Cell Stories for firsthand accounts from people working to bring awareness to sickle cell disease. Learn what role you can play in helping their efforts by visiting the OMH Sickle Cell Disease website: minorityhealth.hhs.gov/sicklecell/

The Office of Minority Health U.S. Department of Health and Human Services

Why it’s a problem that pulse oximeters don’t work as well on patients of color? New research ties inaccuracies in pulse oximeter readings to racial disparities in treatment and outcomes.

Source: Megan Lewis | Institute for Medical Engineering and Science

https://news.mit.edu/2022/pulse-oximeters-dont-work-as-well-patients-of-color-0802

Why it’s a problem that pulse oximeters don’t work as well on patients of color It's well known that pulse oximeters don’t work as well on patients of color. New research links inaccuracies to racial disparities in treatment and outcomes for non-white patients.

What an amazing journey. We are to the staff, mentors, and extended family. Today, we present and continue to move forward.

On August 16, the President signed a $700 billion+ bill into law which included health care policies as mentioned below:

Health Care Policy

The health care provisions in the IRA focus on three groups – pharmaceutical companies, Medicare beneficiaries and individuals accessing coverage on the federal marketplace or state exchange. We’ll look at each a bit below.

Pharmaceutical companies. Historically, Medicare was not able to negotiate with drug manufacturers on the cost of drugs. The IRA changes that for the first time. The Department of Health & Human Services (HHS) is now authorized to negotiate on certain drugs (brand-name and biologics) in Medicare Parts B and D. That said, there are limitations to this authority, such as the brand-name or biologic cannot have a generic or biosimilar available and the drugs have to have been on the market at least nine or 13 years, depending on drug type. Additionally, the number of drugs HHS can negotiate is capped at 10 Part D drugs beginning in 2026. That number rises to 20 Part D and B drugs by 2029. Other policies cover how the negotiated price works and financial penalties for drug companies that fail to negotiate.

Beginning 2023, pharmaceutical companies will owe a rebate if certain drug prices increase more than the rate of inflation (CPI-U). The base year is set at 2021. Rebates would apply to single-source drugs or biologics under Part B and all drugs under Part D (except if annual cost is under $100).

Medicare Beneficiaries. The law assists beneficiaries with the cost of drugs through a variety of policies. One of the more high-profile issues in the press over the past few years has been the cost of insulin. While the legislation initially tried to cap insulin costs for Medicare and privately insured, the latter was struck from the bill. As enacted, the IRA caps cost sharing in Medicare for insulin at $35 monthly beginning in 2023. Also starting in 2023 are policies that eliminate cost-sharing for adult vaccines in Medicare and require state Medicaid/CHIP programs to cover approved vaccines and administration without cost sharing. Beginning in 2025, the law places a $2,000 cap on out-of-pocket spending in Part D among other policy changes.

Thanks to Jennifer Boese is the Director of Health Care Policy at CLA for this information.

Fatal Drug ODs Are Soaring, Especially Among Minorities: CDC

Some of the disparities were stunning:

In 2020, the overdose death rate among Black males 65 and older was nearly seven times that of white males of the same age.

Young Black people (ages 15–24) suffered the largest rate increase (86%) in overdose deaths from 2019 to 2020.

Among American Indian/Alaska Native women, those aged 25–44 saw overdose death increases that were nearly two times that of white women of the same age.

If you or someone you know is struggling with drug addiction, talk to your doctor or call Substance Abuse and Mental Health Services Administration's (SAMHSA) National Helpline at 1-800-662-HELP or go to SAMHSA’s Behavioral Health Treatment Services.

https://www.drugs.com/news/fatal-ods-soaring-especially-among-minorities-cdc-106676.html?utm_source=ddc&utm_medium=email&utm_campaign=Daily+Mednews+++July+20++2022&utm_content=Fatal+Drug+ODs+Are+Soaring++Especially+Among+Minorities++CDC&hash2=56334cfb0f5ca06e4ae5770c95520fc7

Fatal Drug ODs Are Soaring, Especially Among Minorities: CDC - Drugs.com MedNews The nation s opioid epidemic is hitting minorities the hardest, with the latest government study reporting the steepest increases in overdose deaths among Black

New York fund to publicly apologize for its role in Tuskegee syphilis study.

Milbank Memorial Fund, which covered funeral expenses, to say sorry 50 years after study revealed and halted.

https://www.theguardian.com/us-news/2022/jun/11/uskegee-syphilis-study-new-york-fund-apology

New York fund to publicly apologize for its role in Tuskegee syphilis study Milbank Memorial Fund, which covered funeral expenses, to say sorry 50 years after study revealed and halted

Our Chief Medical Officer, James H. Powell, MD will present at the Meeting the Challenge Summit in Washington, DC, on June 10-11, 2022. in helping to define the challenges that impede progress in creating a diverse cohort of study participants and to develop recommendations to overcome barriers to progress. Skin of Color Society

We are happy to announce knowRX is a UCSF Rosenman Innovator Company! Read more about Rosenman and the amazing companies that made the list.

https://rosenmaninstitute.org/2022/06/the-ucsf-rosenman-institute-announces-the-2022-rosenman-innovators

Rosenman Institute thank you for the support and we are grateful for the newly established relationship with you all.

We are glad to announce our selection into Techstars Boston Accelerator along with these eleven other amazing companies. Our journal continues to help change that is all inclusive and reducing the impact of medication side-effects.